0 NASDAQ Companies - September 9, 2019Atara Biotherapeutics to Present Initial Efficacy and Additional Safety Results from Phase 1 Study of ATA188 in Patients with Progressive Multiple Sclerosis at ECTRIMS 2019Read More
0 NASDAQ Companies - September 9, 2019Synthorx to Present at the 2019 World Congress of InflammationRead More
0 NASDAQ Companies - September 9, 2019Harvard Bioscience Announces Strategic Action Plan and Financial TargetsRead More
0 NASDAQ Companies - September 9, 2019Synaptics to Showcase Smart Edge AI, Turnkey Media Streamer Solutions at IBC 2019Read More
0 NASDAQ Companies - September 9, 2019Bionano Genomics to Present at the H.C. Wainwright 21st Annual Global Investment ConferenceRead More
0 NASDAQ Companies - September 9, 2019NBN Co Adopts Infinera Transcend Network Automation Solution to Enhance Australia’s Open-access Broadband NetworkRead More
0 NASDAQ Companies - September 9, 2019Blucora To Unify Wealth Management Divisions as Avantax℠Read More
0 NASDAQ Companies - September 9, 2019Ovid Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment ConferenceRead More
0 NASDAQ Companies - September 9, 2019TYME Presents Positive Circulating Tumor Cell Data from TYME-88-Panc Study in Patients with Advanced Pancreatic Cancer at AACR PANC 2019Read More
